Drs. Marc Tessier-Lavigne and Robert Malenka Join Scientific Advisory Board

Posted: Jan. 29, 2013

Cure Alzheimer's Fund (CAF) welcomes two new Scientific Advisory Board (SAB) members: Marc Tessier-Lavigne, Ph.D., president of The Rockefeller University, and former CAF Research Consortium member Robert C. Malenka, M.D., Ph.D., of Stanford University. Tessier-Lavigne and Malenka join Dennis Choi, M.D., Ph.D., Simons Foundation; Caleb Finch, Ph.D., University of Southern California; Nobel Laureate Paul Greengard, Ph.D., The Rockefeller University; Stephen Heinemann, Ph.D., The Salk Institute for Biological Studies; John S. Lazo, Ph.D., University of Pittsburgh; and SAB Chair John C. Mazziotta, M.D., Ph.D., UCLA.

The role of the Scientific Advisory Board is to help direct the research roadmap, oversee funded projects and maintain the scientific integrity of Cure Alzheimer's Fund.
To read about each of them, click on their name above.